How many stocks are there of LivaNova?
The current number of stocks of LivaNova is 54.21 M undefined.
LivaNova Stocks 2024
LivaNova Stocks
54.21 M
Ticker
LIVN
ISIN
GB00BYMT0J19
WKN
A14156
In 2024, LivaNova had 54.21 M outstanding stocks, a 0% change from the 54.21 M stocks in the previous year.
The LivaNova Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2028e | 54.21 |
| 2027e | 54.21 |
| 2026e | 54.21 |
| 2025e | 54.21 |
| 2024e | 54.21 |
| 2023 | 54.21 |
| 2022 | 53.47 |
| 2021 | 50.63 |
| 2020 | 48.59 |
| 2019 | 48.35 |
| 2018 | 48.5 |
| 2017 | 48.16 |
| 2016 | 48.86 |
| 2015 | 32.74 |
| 2014 | 26.63 |
| 2013 | 27.47 |
| 2012 | 28.01 |
| 2011 | 28.31 |
| 2010 | 28.61 |
| 2009 | 28.7 |
| 2008 | 27.54 |
| 2007 | 26.57 |
| 2006 | 25.51 |
| 2005 | 24.92 |
| 2004 | 24.04 |
LivaNova shares outstanding GB00BYMT0J19 · A14156
The number of shares was LivaNova in 2023 — This indicates how many shares 54.212 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue LivaNova earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates LivaNova's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of LivaNova’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating LivaNova's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 24.04 M Aktien |
| 2005 | 24.92 M Aktien |
| 2006 | 25.51 M Aktien |
| 2007 | 26.57 M Aktien |
| 2008 | 27.54 M Aktien |
| 2009 | 28.7 M Aktien |
| 2010 | 28.61 M Aktien |
| 2011 | 28.31 M Aktien |
| 2012 | 28.01 M Aktien |
| 2013 | 27.47 M Aktien |
| 2014 | 26.63 M Aktien |
| 2015 | 32.74 M Aktien |
| 2016 | 48.86 M Aktien |
| 2017 | 48.16 M Aktien |
| 2018 | 48.5 M Aktien |
| 2019 | 48.35 M Aktien |
| 2020 | 48.59 M Aktien |
| 2021 | 50.63 M Aktien |
| 2022 | 53.47 M Aktien |
| 2023 | 54.21 M Aktien |
| 2024e | 54.21 M Aktien |
| 2025e | 54.21 M Aktien |
| 2026e | 54.21 M Aktien |
| 2027e | 54.21 M Aktien |
| 2028e | 54.21 M Aktien |
LivaNova Aktienanalyse
What does LivaNova do?
LivaNova PLC is a global medical technology company specializing in the development and manufacturing of devices and therapies for cardiovascular diseases, epilepsy, and brain disorders. The company was founded in 2015 through the merger of Sorin Group and Cyberonics, and in 2019, a legal dispute resulted in the agreement to make compensation payments. The company is divided into three main divisions: cardiac surgery, neuromodulation, and cardiac rhythm management. Each division offers different products for their target markets. The cardiac surgery division provides devices for surgical treatment of cardiovascular diseases, such as heart valve repair and replacement systems, cardioplegia systems for heart cooling during surgery, and mechanical heart support systems for patients with severe heart failure. Neuromodulation specializes in the treatment of epilepsy, brain injuries, and psychiatric disorders. The division offers both implantable devices directly implanted in the brain and external devices that use magnetic fields to influence brain activity. The cardiac rhythm management division focuses on the treatment of heart rhythm disorders and offers pacemakers, implantable cardioverter-defibrillators (ICDs), catheters, and ablation systems to correct electrical changes in the heart. LivaNova is headquartered in London and has manufacturing facilities in North America, Europe, and Asia. The company works closely with clinical partners worldwide to understand the medical needs of patients and develop new products and therapies aimed at improving patients' lives. Overall, LivaNova's business model is centered around commitment to innovation, production, and global presence. The company aims to improve the quality of healthcare and provide better therapies and devices to patients worldwide. The focus of product development is often a balance of effectiveness, safety, and patient comfort. The answer is: LivaNova is a global medical technology company specializing in the development and manufacturing of devices and therapies for cardiovascular diseases, epilepsy, and brain disorders. LivaNova ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating LivaNova's Shares Outstanding
LivaNova's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in LivaNova’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding LivaNova’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in LivaNova’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about LivaNova stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of LivaNova are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of LivaNova evolved in recent years?
The number of shares of LivaNova has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. LivaNova as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of LivaNova?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does LivaNova pay?
Over the past 12 months, LivaNova paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, LivaNova is expected to pay a dividend of 0 USD.
What is the dividend yield of LivaNova?
The current dividend yield of LivaNova is .
When does LivaNova pay dividends?
LivaNova pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of LivaNova?
LivaNova paid dividends every year for the past 0 years.
What is the dividend of LivaNova?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is LivaNova located?
LivaNova is assigned to the 'Health' sector.
Wann musste ich die Aktien von LivaNova kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of LivaNova from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did LivaNova pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of LivaNova in the year 2023?
In the year 2023, LivaNova distributed 0 USD as dividends.
In which currency does LivaNova pay out the dividend?
The dividends of LivaNova are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The LivaNova stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von LivaNova
Our stock analysis for LivaNova Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LivaNova Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
